TARS Tarsus Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1819790 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $19.96M 28 sales by 9 insiders
- Filings on record
- 278 since 2021-08-06, latest 2026-09-17 16:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.18M |
| LINK WILLIAM J PHD | Dir | — | $4.48M |
| Whitfield Dianne C. | CHRO | — | $2.69M |
| Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| Neervannan Seshadri | COO | — | $2.00M |
| Farrow Jeffrey S | See Remarks | — | $1.32M |
| Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| Wahl Bryan | GC | — | $850.4K |
| Goodrich Katherine | Dir | — | $183.4K |
| Goldberg Andrew D. | Dir | — | — |
Transactions 236
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-10-21 | 2022-10-19 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $16.92 | -8,000 | 1.16M | -0.7% | -$135.3K |
| MI | 2022-10-14 | 2022-10-12 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $15.91 | -9,000 | 1.17M | -0.8% | -$143.2K |
| MI | 2022-09-23 | 2022-09-21 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $16.31 | -8,000 | 1.18M | -0.7% | -$130.5K |
| 2022-09-16 | 2022-09-15 | TARS | Greenstein Leonard M. | CFO | S - Sale | $16.03 | -5,000 | 59.3K | -8% | -$80.2K | |
| MI | 2022-09-16 | 2022-09-14 | TARS | Lin Elizabeth Yeu | Dir | P - Purchase | $16.12 | +18.4K | 6,360 | New | +$296.6K |
| I | 2022-09-16 | 2022-09-14 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $16.01 | -9,000 | 1.19M | -0.8% | -$144.1K |
| DM | 2022-08-26 | 2022-08-24 | TARS | Mottiwala Aziz | Chief Commercial Off | M - OptEx | $9.42 | +5,188 | 55.8K | +10% | +$48.9K |
| 2022-08-19 | 2022-08-18 | TARS | Greenstein Leonard M. | CFO | S - Sale | $16.30 | -5,000 | 64.3K | -7% | -$81.5K | |
| MI | 2022-08-19 | 2022-08-17 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $16.59 | -8,000 | 1.20M | -0.7% | -$132.7K |
| MI | 2022-08-17 | 2022-08-15 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -211.8K | 646.7K | -25% | $0 |
| D | 2022-06-17 | 2022-06-15 | TARS | Ackermann Michael | Dir | M - OptEx | — | +4,257 | 1.21M | +0.4% | — |
| I | 2022-05-09 | 2022-05-05 | TARS | Ackermann Michael | Dir | P - Purchase | $13.50 | +100.0K | 100.0K | New | +$1.35M |
| I | 2022-05-05 | 2022-05-05 | TARS | Vivo Capital IX, LLC | 10% | S - Sale | $12.25 | -5,374 | 2.47M | -0.2% | -$65.8K |
| MI | 2022-05-04 | 2022-05-02+ | TARS | Vivo Capital Fund IX, L.P. | 10% | S - Sale | $13.39 | -513.0K | 2.49M | -17% | -$6.87M |
| M | 2021-12-03 | 2021-12-01 | TARS | Ackermann Michael | Dir | S - Sale | $24.68 | -5,833 | 1.21M | -0.5% | -$143.9K |
| MI | 2021-12-03 | 2021-12-01 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $24.72 | -5,833 | 1.20M | -0.5% | -$144.2K |
| MI | 2021-11-16 | 2021-11-11 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -245.7K | 862.3K | -22% | $0 |
| 2021-11-10 | 2021-11-08 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $28.11 | -1,889 | 50.2K | -4% | -$53.1K | |
| M | 2021-11-08 | 2021-11-04+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $28.04 | -111 | 52.1K | -0.2% | -$3,112 |
| M | 2021-11-04 | 2021-11-02 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $26.78 | -6,000 | 52.2K | -10% | -$160.7K |
| M | 2021-11-03 | 2021-11-01 | TARS | Ackermann Michael | Dir | S - Sale | $27.82 | -5,833 | 1.21M | -0.5% | -$162.3K |
| MI | 2021-11-03 | 2021-11-01 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $27.82 | -5,833 | 1.21M | -0.5% | -$162.3K |
| M | 2021-10-14 | 2021-10-12 | TARS | Ackermann Michael | Dir | S - Sale | $26.27 | -5,633 | 1.22M | -0.5% | -$148.0K |
| MI | 2021-10-14 | 2021-10-12 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $26.30 | -5,531 | 1.22M | -0.5% | -$145.4K |
| I | 2021-10-12 | 2021-10-08 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $25.02 | -302 | 1.22M | -0.0% | -$7,556 |
| 2021-10-12 | 2021-10-08 | TARS | Ackermann Michael | Dir | S - Sale | $25.03 | -200 | 1.22M | -0.0% | -$5,006 | |
| DM | 2021-09-14 | 2021-09-10 | TARS | Mottiwala Aziz | Chief Commercial Off | M - OptEx | $7.05 | +6,943 | 58.2K | +14% | +$49.0K |
| D | 2021-09-14 | 2021-09-10 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale+OE | $22.15 | -2,593 | 58.2K | -4% | -$57.4K |
| 2021-09-03 | 2021-09-01 | TARS | Ackermann Michael | Dir | S - Sale | $25.24 | -5,833 | 1.22M | -0.5% | -$147.2K | |
| MI | 2021-09-03 | 2021-09-01 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $25.25 | -5,833 | 1.22M | -0.5% | -$147.3K |
| 2021-08-12 | 2021-08-11 | TARS | Ackermann Michael | Dir | S - Sale | $25.15 | -621 | 1.23M | -0.1% | -$15.6K | |
| MI | 2021-08-12 | 2021-08-10+ | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $25.07 | -2,020 | 1.23M | -0.2% | -$50.6K |
| MI | 2021-08-10 | 2021-08-06+ | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $25.01 | -2,443 | 1.23M | -0.2% | -$61.1K |
| M | 2021-08-10 | 2021-08-06+ | TARS | Ackermann Michael | Dir | S - Sale | $25.00 | -3,829 | 1.23M | -0.3% | -$95.7K |
| M | 2021-08-06 | 2021-08-05 | TARS | Ackermann Michael | Dir | S - Sale | $25.00 | -1,383 | 1.23M | -0.1% | -$34.6K |
| I | 2021-08-06 | 2021-08-05 | TARS | Azamian Bobak R. | Pres, CEO, Dir | S - Sale | $25.00 | -1,370 | 1.23M | -0.1% | -$34.2K |
Purchase Sale Sale after option exercise All abbreviations